Advanced technologies in extracellular matrix (ECM) mimicry are driving breakthroughs in regenerative medicine, tissue engineering, and drug delivery. ECM plays a vital role in maintaining tissue architecture and regulating cellular functions. By leveraging cutting-edge technologies, researchers can create ECM-mimicking materials that closely replicate the structure, composition, and biological functions of natural tissues, enabling more effective therapeutic strategies. One significant advancement is 3D bioprinting, which allows the precise fabrication of ECM-like scaffolds with controlled architecture and biomolecule distribution. These scaffolds replicate the mechanical and biochemical properties of native tissues, promoting cell growth and tissue repair. Microfluidic technology has further enabled the development of ECM models that simulate tissue-specific environments, aiding the study of cell-ECM interactions and supporting the creation of organ-on-a-chip systems for drug testing. Nanotechnology has also contributed significantly to ECM mimicry. Nanofibrous scaffolds, produced through electrospinning, mimic the fibrous networks of natural ECM. These nanofibers can be functionalized with bioactive molecules to guide cell behavior and enhance tissue regeneration. Also, Advances in hydrogel technology have produced smart hydrogels that respond to stimuli like temperature or pH, imitating the dynamic nature of the ECM. These hydrogels are being explored for applications in wound healing and targeted drug delivery. Advanced technologies in ECM mimicry are revolutionizing tissue repair and regenerative medicine by providing bio functional, tailored solutions for a wide range of medical applications.